
is a spin off company
Centre for Genomic Regulation (Barcelona - Spain) from the
founded by experienced entrepreneurs and funded

Pulmobiotics will use its technology to discover and develop novel treatments and vaccines for respiratory diseases, which are among the most common causes of severe illness and death worldwide.
Pulmobiotics | Platform | Respiratory diseases | Partners | Team | Contact